company background image
2230

Saudi Chemical Holding SASE:2230 Stock Report

Last Price

ر.س30.20

Market Cap

ر.س2.5b

7D

11.2%

1Y

-26.0%

Updated

27 Jun, 2022

Data

Company Financials
2230 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends1/6

2230 Stock Overview

Saudi Chemical Holding Company engages in the explosives, medicines and medical supplies, and production of ammonium nitrate businesses in the Kingdom of Saudi Arabia and internationally.

Saudi Chemical Holding Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Saudi Chemical Holding
Historical stock prices
Current Share Priceر.س30.20
52 Week Highر.س43.25
52 Week Lowر.س27.00
Beta0.49
1 Month Change-8.49%
3 Month Change-12.84%
1 Year Change-25.98%
3 Year Change29.06%
5 Year Change4.70%
Change since IPO51.71%

Recent News & Updates

Shareholder Returns

2230SA HealthcareSA Market
7D11.2%0.8%2.0%
1Y-26.0%19.2%12.7%

Return vs Industry: 2230 underperformed the SA Healthcare industry which returned 19.2% over the past year.

Return vs Market: 2230 underperformed the SA Market which returned 12.7% over the past year.

Price Volatility

Is 2230's price volatile compared to industry and market?
2230 volatility
2230 Average Weekly Movement4.6%
Healthcare Industry Average Movement4.9%
Market Average Movement4.8%
10% most volatile stocks in SA Market7.0%
10% least volatile stocks in SA Market3.1%

Stable Share Price: 2230 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 2230's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1972n/aThamer Al-Muhaidhttps://www.saudichemical.com

Saudi Chemical Holding Company engages in the explosives, medicines and medical supplies, and production of ammonium nitrate businesses in the Kingdom of Saudi Arabia and internationally. The company manufactures and sells explosives and their derivatives for civil and military uses, as well as provides technical support services for explosions. It also engages in the manufacturing, wholesale, and retail trading of medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools and equipment, supplies of hospitals and medical centers, and its related spare parts and food items; and manufacturing of ammonium nitrate.

Saudi Chemical Holding Fundamentals Summary

How do Saudi Chemical Holding's earnings and revenue compare to its market cap?
2230 fundamental statistics
Market Capر.س2.55b
Earnings (TTM)ر.س61.45m
Revenue (TTM)ر.س3.35b

41.4x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2230 income statement (TTM)
Revenueر.س3.35b
Cost of Revenueر.س2.92b
Gross Profitر.س429.65m
Other Expensesر.س368.20m
Earningsر.س61.45m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.73
Gross Margin12.84%
Net Profit Margin1.84%
Debt/Equity Ratio126.0%

How did 2230 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

68%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 2230 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2230?

Other financial metrics that can be useful for relative valuation.

2230 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.4x
Enterprise Value/EBITDA25x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 2230's PE Ratio compare to its peers?

2230 PE Ratio vs Peers
The above table shows the PE ratio for 2230 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average70.1x
9530 Arabian International Healthcare Holding
12.9xn/aر.س1.1b
4005 National Medical Care
19.2x10.9%ر.س2.5b
4009 Middle East Healthcare
118.3x34.0%ر.س3.0b
2140 Ayyan Investment
130xn/aر.س1.3b
2230 Saudi Chemical Holding
41.4xn/aر.س2.5b

Price-To-Earnings vs Peers: 2230 is good value based on its Price-To-Earnings Ratio (41.4x) compared to the peer average (70.1x).


Price to Earnings Ratio vs Industry

How does 2230's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Earnings vs Industry: 2230 is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the SA Healthcare industry average (37.9x)


Price to Earnings Ratio vs Fair Ratio

What is 2230's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2230 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio41.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2230's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 2230 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2230 (SAR30.2) is trading above our estimate of fair value (SAR4.22)

Significantly Below Fair Value: 2230 is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2230's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Saudi Chemical Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


14.1%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Saudi Chemical Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of 2230’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Past Performance

How has Saudi Chemical Holding performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-22.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 2230 has high quality earnings.

Growing Profit Margin: 2230's current net profit margins (1.8%) are lower than last year (2.2%).


Past Earnings Growth Analysis

Earnings Trend: 2230's earnings have declined by 22.1% per year over the past 5 years.

Accelerating Growth: 2230's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 2230 had negative earnings growth (-20.1%) over the past year, making it difficult to compare to the Healthcare industry average (2.4%).


Return on Equity

High ROE: 2230's Return on Equity (3.8%) is considered low.


Discover strong past performing companies

Financial Health

How is Saudi Chemical Holding's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 2230's short term assets (SAR3.1B) exceed its short term liabilities (SAR2.6B).

Long Term Liabilities: 2230's short term assets (SAR3.1B) exceed its long term liabilities (SAR419.5M).


Debt to Equity History and Analysis

Debt Level: 2230's net debt to equity ratio (119.1%) is considered high.

Reducing Debt: 2230's debt to equity ratio has increased from 56.9% to 126% over the past 5 years.

Debt Coverage: 2230's debt is not well covered by operating cash flow (9%).

Interest Coverage: 2230's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Saudi Chemical Holding current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


1.65%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 2230's dividend (1.66%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.95%).

High Dividend: 2230's dividend (1.66%) is low compared to the top 25% of dividend payers in the SA market (4.5%).


Stability and Growth of Payments

Stable Dividend: 2230's dividend payments have been volatile in the past 10 years.

Growing Dividend: 2230's dividend payments have fallen over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (68.4%), 2230's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (4868.4%), 2230's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Thamer Al-Muhaid

no data

Tenure

Mr. Thamer Mohammed Al-Muhaid serves as Group Chief Executive Officer of Saudi Chemical Holding Company. Mr. Al-Muhaid served as Deputy General Manager of the Saudi Chemical Company Ltd., General Manager a...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Saudi Chemical Holding Company's employee growth, exchange listings and data sources


Key Information

  • Name: Saudi Chemical Holding Company
  • Ticker: 2230
  • Exchange: SASE
  • Founded: 1972
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: ر.س2.546b
  • Shares outstanding: 84.32m
  • Website: https://www.saudichemical.com

Location

  • Saudi Chemical Holding Company
  • P.O. Box 2665
  • Riyadh
  • 11461
  • Saudi Arabia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/27 00:00
End of Day Share Price2022/06/27 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.